Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bruker Corp (BRKR)

Bruker Corp (BRKR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,869,280
  • Shares Outstanding, K 153,085
  • Annual Sales, $ 2,073 M
  • Annual Income, $ 197,200 K
  • 60-Month Beta 1.27
  • Price/Sales 2.86
  • Price/Cash Flow 18.56
  • Price/Book 6.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.33
  • Number of Estimates 6
  • High Estimate 0.37
  • Low Estimate 0.29
  • Prior Year 0.43
  • Growth Rate Est. (year over year) -23.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.27 +5.07%
on 09/21/20
43.25 -9.46%
on 09/02/20
-3.03 (-7.18%)
since 08/25/20
3-Month
37.27 +5.07%
on 09/21/20
48.17 -18.70%
on 08/04/20
+0.64 (+1.66%)
since 06/25/20
52-Week
30.78 +27.23%
on 04/02/20
54.49 -28.13%
on 01/16/20
-4.11 (-9.50%)
since 09/25/19

Most Recent Stories

More News
Bruker's Buyout of Canopy Biosciences Enhances Portfolio

Bruker (BRKR) expands its multi-dimensional immune profiling by adding ChipCytometry tools via the acquisition of Canopy Biosciences.

HOLX : 64.35 (+2.13%)
QGEN : 51.92 (+1.47%)
TMO : 422.29 (+0.99%)
BRKR : 39.16 (+2.14%)
Bruker Announces Acquisition of Canopy Biosciences, LLC

Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition...

BRKR : 39.16 (+2.14%)
The Zacks Analyst Blog Highlights: Mettler-Toledo, PerkinElmer, Waters and Bruker

The Zacks Analyst Blog Highlights: Mettler-Toledo, PerkinElmer, Waters and Bruker

PKI : 119.80 (+1.56%)
WAT : 191.06 (+0.75%)
MTD : 975.07 (+1.54%)
BRKR : 39.16 (+2.14%)
Bruker Banks on Strategic Innovation Amid Coronavirus Crisis

At Bruker's (BRKR) Germany campus, the company currently offers a pilot COVID-19 at work testing program for its factory workforce.

HOLX : 64.35 (+2.13%)
TMO : 422.29 (+0.99%)
GMED : 49.21 (+0.78%)
BRKR : 39.16 (+2.14%)
4 Stocks to Watch on Rising Demand for Scientific Instruments

4 Stocks to Watch on Rising Demand for Scientific Instruments

WAT : 191.06 (+0.75%)
PKI : 119.80 (+1.56%)
MTD : 975.07 (+1.54%)
BRKR : 39.16 (+2.14%)
Bruker Appoints Bonnie H. Anderson to its Board of Directors

Bruker Corporation (Nasdaq: BRKR) today announced that it has appointed Bonnie H. Anderson to serve on its board of directors, effective as of September 3, 2020.

BRKR : 39.16 (+2.14%)
Bruker Corporation to Participate in the 2020 Wells Fargo Virtual Healthcare Conference

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2020 Wells Fargo Virtual Healthcare Conference. Frank Laukien, Chairman, President & CEO will participate in an analyst moderated...

BRKR : 39.16 (+2.14%)
Why Is Bruker (BRKR) Down 4.5% Since Last Earnings Report?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BRKR : 39.16 (+2.14%)
Bruker Rides on MALDI Launches Amid Coronavirus-Led Crisis

For higher specific detection of the SARS-CoV-2 virus, Bruker (BRKR) launches luoroType SARS-CoV-2 plus next-generation 6-plex PCR assay.

QGEN : 51.92 (+1.47%)
TMO : 422.29 (+0.99%)
LHCG : 202.83 (+3.42%)
BRKR : 39.16 (+2.14%)
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins

Bruker Corporation (Nasdaq: BRKR) today announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins...

BRKR : 39.16 (+2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BRKR with:

Business Summary

As of February 26, 2008, the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group, Bruker Corporation now operates in two segments, the life science and analytical (LSA) systems segment, and...

See More

Key Turning Points

2nd Resistance Point 40.31
1st Resistance Point 39.73
Last Price 39.16
1st Support Level 38.21
2nd Support Level 37.27

See More

52-Week High 54.49
Fibonacci 61.8% 45.43
Fibonacci 50% 42.64
Fibonacci 38.2% 39.84
Last Price 39.16
52-Week Low 30.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar